SecBot SecBot
3 ·Filed Nov 12, 2026
WW

WWB

WINDWARD BIO GROUP AG
NEUTRAL
Impact 3/10
Horizonweeks Processed4d 4h ago SEC0002162137-26-000003
Actionable Insight • Neutral

These Form 3 filings confirm insider ownership ahead of an expected IPO. The large insider stakes (CEO ~4.6M shares, CMO ~642K shares, director Stampacchia ~3.6M shares via funds) indicate significant alignment with shareholders. Monitor the IPO prospectus for pricing and lock-up details.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1
Entry
$28.50
T+0 close · Nov 12, 2026 · via day close
Latest settled
+5.40%
T+1 · $30.04
Vs SPY
+7.32%
α at T+1
Next horizon
T+5
in 3d
  1. T+0 · Nov 13 $28.50entry
  2. T+1 · 15h ago +5.40%α +7.32% · $30.04
  3. T+5 · in 3d Pending
  4. T+20 · in 27d Pending
  5. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Four Form 3 filings were filed on November 12, 2026, by insiders of Windward Bio Group AG (WWB), a pre-IPO biotech company. The filings disclose initial beneficial ownership for CEO Luca Santarelli (4,578,110 common shares and options for 163,854 shares), CMO Omar Khwaja (642,136 common shares and options for 318,830 shares), director Otello Stampacchia (indirect holdings via Omega funds totaling 3,590,530 common shares on an as-converted basis), and director Sandip Kapadia (no securities reported). These filings are routine initial ownership disclosures required upon becoming Section 16 reporting persons, likely in connection with the company's upcoming IPO.

Key Facts

  • CEO Luca Santarelli holds 4,578,110 common shares and options to purchase 163,854 common shares at $0.02 per share, vesting over 36 months from April 30, 2026.
  • CMO Omar Khwaja holds 642,136 common shares and options to purchase 318,830 common shares at $0.02 per share, vesting over 36 months from April 30, 2026.
  • Director Otello Stampacchia reports indirect beneficial ownership of 3,590,530 common shares (on an as-converted basis) through Omega Fund VII, L.P. and Omega Fund VIII, L.P., including Series A and Series B preferred shares convertible 1:1 into common shares.
  • Director Sandip Kapadia reports no securities beneficially owned.
  • All four filings include a power of attorney authorizing Scott Applebaum, Diego Ramos, and Claudia D'Augusta to execute Section 16 filings on their behalf.

Financial Impact

Insider holdings disclosed; no transaction or monetary value stated beyond option exercise price of $0.02 per share.

Risk Factors

  • No financial data or guidance provided; pre-revenue biotech with no disclosed product revenue or clinical trial results.
  • Pre-IPO stage means high uncertainty on valuation and market reception.

Documents Analyzed

This report is based on 16 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (WWB), Batch item 10002162137-26-000003
Document: 0002162137-26-000003-index-headers.html0001776393-26-000005
Document: 0002162137-26-000003-index.html0001361712-26-000007
Document: 0002162137-26-000003.txt0001677141-26-000009
3 Filing (WWB), Batch item 50001776393-26-000005
Document: 0001776393-26-000005-index-headers.html0002162137-26-000003
Document: 0001776393-26-000005-index.html0002162137-26-000003
Document: 0001776393-26-000005.txt0002162137-26-000003
3 Filing (WWB), Batch item 90001361712-26-000007
Document: 0001361712-26-000007-index-headers.html0002162137-26-000003
Document: 0001361712-26-000007-index.html0002162137-26-000003
Document: 0001361712-26-000007.txt0002162137-26-000003
3 Filing (WWB), Batch item 130001677141-26-000009
Document: 0001677141-26-000009-index-headers.html0002162137-26-000003
Document: 0001677141-26-000009-index.html0002162137-26-000003
Document: 0001677141-26-000009.txt0002162137-26-000003

US Market Status

Market Closed · Opens Wed (11h 12m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 12, 2026